US Patent 10517949 Anti-PD-L1 antibodies
Patent 10517949 was granted and assigned to Agency for Science, Technology and Research on December, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+248 characters)
Article
Patent abstract
Anti-PD-L1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and methods of using such antibodies to restore T-cell function in T-cells exhibiting T-cell exhaustion or T-cell anergy.
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Cheng-i Wang0
Hsueh Ling Janice Oh0
Siok Ping Yeo0
Edits on 30 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105179490
Date of Patent
December 31, 2019
0Patent Application Number
155420230
Date Filed
January 4, 2016
0Patent Citations Received
Patent Primary Examiner
Edits on 19 Apr, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 28 Dec, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10517949 Anti-PD-L1 antibodies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10517949
Date of patent
December 31, 2019
Patent application number
15542023
Date Filed
January 4, 2016
Patent primary examiner
Find more entities like US Patent 10517949 Anti-PD-L1 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
